Latest news

Shareholder disclosures can be found here.
 
Showing 1-6 of 6
27 April 2012
Interim report 1, 2012

Revenue growth in Americas and Asia offset by decline in Europe; slightly improved profitability

29 March 2012
The Annual General Meeting of Nobel Biocare approves all proposals of the Board of Directors

Nobel Biocare Holding AG’s Annual General Meeting today endorsed all proposals put forward by the Board of Directors.

20 March 2012
Six Nobel Biocare scientific symposia in 2012 will celebrate the dual anniversaries of osseointegration – 60 years since the discovery and 30 years since the landmark conference in Toronto

In 2012 Nobel Biocare will host a series of six scientific symposia in selected cities from Europe to North America to celebrate the dual anniversaries of the advent and acknowledgement of osseointegration. The year 2012 marks 60 years since Professor Per-Ingvar Brånemark discovered the principles of osseointegration and 30 years since its international acceptance at the landmark conference in Toronto. "Nobel Biocare Symposia 2012" will take place in Sweden, Canada, and also France, Ukraine, Germany and Italy.

6 March 2012
Nobel Biocare appoints Frank Mengis as Head of Global Operations

Nobel Biocare announced today that Frank Mengis will be appointed Senior Vice President Global Operations and member of the Executive Committee, effective 1 July 2012. He will replace Ernst Zaengerle, who will be retiring.

9 February 2012
Full year report, 2011

Business improvements remain on track

Showing 1-6 of 6 

Investor contacts

Süha Demokan

Süha Demokan

Head of Investor Relations

Nobel Biocare Management AG  
P.O. Box
CH - 8058 Zurich-Airport
Switzerland

+41 43 211 42 30

+41 79 430 81 46

+41 43 211 42 42

Give us your feedback!

Summarize your comments
Email